21 January 2004 13:10
Isonics Corporation and GST Extend Agreement for Joint Production and Marketing of Oxygen-18 Through July 2010
/Health/Medical Writers
GOLDEN, Colo.--(BUSINESS WIRE)--Jan. 21, 2004--Isonics Corporation (NASDAQ: ISON), a leader in the development of
isotopically engineered semiconductor materials, a supplier of silicon-on-insulator (SOI) wafers and isotopes for life
sciences and health care applications, announced that it has extended the joint cooperation agreement with Global
Scientific Technologies (GST), its partner for the last 5 years, through July 2010. GST is a St. Petersburg,
Russia-based manufacturer of oxygen-18 used to produce positron emission tomography (PET) radiopharmaceuticals. GST is
one of the world's largest producers of oxygen-18.
"Together with GST over the past five years we have become recognized as a world-wide leader in oxygen-18
product quality, customer service and innovation," commented Dr. Daniel J. Grady, vice president of Isonics'
Life Sciences segment. "With a substantial backlog and having secured several large orders recently, this extension
agreement is intended to assure our customers of our ability to continue providing them with a superior product and
ensures our ability to support their growing oxygen-18 demands. In addition, our production plan has built-in capacity
increases for the next three years. Future increases will be evaluated regularly."
"Isonics has been an invaluable partner for GST from the beginning of our production and marketing
efforts", commented Dr. Vladimir A. Shishkunov, general director and founder of GST. "Together we have very
successfully navigated this complex and dynamic business. We look forward to continuing and growing this partnership
with Isonics, building on the foundation we have jointly developed over the last five years."
--30--SS/ny* CONTACT: Investor Relations: Lippert/Heilshorn & Associates David K. Waldman/Jody Burfening, 212-838-3777
dwaldman@lhai.com or Isonics Corporation Dr. Daniel J. Grady, 410-381-5254 www.isonics.com
About Isonics Corporation
Isonics is a world leader in isotopically engineered materials and produces isotopically pure silicon-28 chemicals
and wafers and silicon-on-insulator wafers (SOI) for the semiconductor industry. Isonics also markets and sells stable
isotopes for the health care industry such as Oxygen-18 for positron emission tomography (PET) imaging. The company is
also a leading supplier of several radioactive isotopes used in medical imaging and therapy. Isotopes can be thought of
as ultra pure materials. For additional information visit www.isonics.com.
Except for historical information contained herein, this document contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks and
uncertainties that may cause the Company's actual results or outcomes to be materially different from those
anticipated and discussed herein, and which may result in the parties being unable or unwilling to complete the
transaction described herein. Further, the Company operates in industries where securities values may be volatile and
may be influenced by regulatory and other factors beyond the Company's control. Other important factors that the
Company believes might cause such differences are discussed in the risk factors detailed in the Company's 10-KSB
for the year ended April 30, 2003 as filed with the Securities and Exchange Commission, which include the Company's
cash flow difficulties, dependence on significant customers, and rapid development of technology, among other risks. In
assessing forward-looking statements contained herein, readers are urged to carefully read all cautionary statements
contained in the Company's filings with the Securities and Exchange Commission.
[CAIW [Corporate Announcements Intelligence Wire]] |
RUSSIA IN FACTS
